NewsBenzingaIntegra Lifesciences Affirms FY2026 Adj EPS Guidance of $2.30-$2.40 vs $2.42 Est; Affirms FY2026 Sales Guidance of $1.634B-$1.654B vs $1.661B Est Integra Lifesciences Affirms FY2026 Adj EPS Guidance of $2.30-$2.40 vs $2.42 Est; Affirms FY2026 Sales Guidance of $1.634B-$1.654B vs $1.661B Est Benzinga 2026.10.21 10:01 (GMT+0) Open on Benzinga Other news Here’s How Much You Would Have Made Owning Visa Stock In The Last 15 Years Here's How Much $1000 Invested In PBF Energy 5 Years Ago Would Be Worth Today Kevin O’Leary Says Tesla-SpaceX Merger Is Inevitable After Flying Roadster Demo — ‘If You Own Tesla, You’re Gonna Own New Company’ Blackstone’s Jas Khaira says fears over AI-buildout debt are overblown Cathay General Q3 2026 Earnings Call Transcript Meta wants to pay for its broad AI buildout with a newly created class of stock
Kevin O’Leary Says Tesla-SpaceX Merger Is Inevitable After Flying Roadster Demo — ‘If You Own Tesla, You’re Gonna Own New Company’